What is Stoko?
Stoko operates at the intersection of medical device engineering and high-performance apparel. By integrating sophisticated support structures directly into wearable garments, the company provides users with clinical-grade stability without the bulk of traditional bracing. This unique value proposition positions Stoko as a leader in musculoskeletal health, catering to both professional athletes requiring injury prevention and patients undergoing long-term rehabilitation. The company's focus on human-centric design and rigorous product development has established it as a formidable entity within the Canadian health-tech ecosystem, effectively bridging the gap between medical necessity and consumer-grade accessibility.
How much funding has Stoko raised?
Stoko has raised a total of $4.7M across 1 funding round:
Angel/Seed
$4.7M
Angel/Seed (2021): $4.7M, investors not publicly disclosed
Key Investors in Stoko
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Stoko?
With this major strategic investment, Stoko is well-positioned to scale its manufacturing capabilities and broaden its distribution channels across North America. The current lifecycle stage, defined by major enterprise-level funding, suggests a transition from initial product validation to aggressive market penetration. Future strategic initiatives will likely prioritize the expansion of their research and development pipeline, potentially incorporating advanced materials science to enhance the efficacy of their support technology. As the company matures, the focus will shift toward securing broader clinical partnerships and integrating their wearable solutions into standard physical therapy protocols, thereby cementing their role as a critical component of the modern injury recovery landscape.
See full Stoko company page
